247 related articles for article (PubMed ID: 31827075)
1. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.
Yu S; Zhang Y; Li Q; Zhang Z; Zhao G; Xu J
Cell Death Dis; 2019 Dec; 10(12):949. PubMed ID: 31827075
[TBL] [Abstract][Full Text] [Related]
2. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
3. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
4. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
[TBL] [Abstract][Full Text] [Related]
5. A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma.
Liu J; Zhao X; Wang K; Zhang X; Yu Y; Lv Y; Zhang S; Zhang L; Guo Y; Li Y; Yang A; Zhang R; Li J
Cell Death Dis; 2019 Jun; 10(6):452. PubMed ID: 31175271
[TBL] [Abstract][Full Text] [Related]
6. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α.
Kojima M; Sugimoto K; Kobayashi M; Ichikawa-Tomikawa N; Kashiwagi K; Watanabe T; Soeda S; Fujimori K; Chiba H
Mol Cancer Res; 2021 Jul; 19(7):1208-1220. PubMed ID: 33727343
[TBL] [Abstract][Full Text] [Related]
8. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
9. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract][Full Text] [Related]
10. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
11. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
12. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
14. RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription.
Wang J; Huang F; Shi Y; Zhang Q; Xu S; Yao Y; Jiang R
Gastric Cancer; 2021 Jan; 24(1):85-102. PubMed ID: 32623586
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
[TBL] [Abstract][Full Text] [Related]
16. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop.
Huang S; Cao Y; Guo H; Yao Y; Li L; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2020 Oct; 24(19):11133-11145. PubMed ID: 32827244
[TBL] [Abstract][Full Text] [Related]
19. SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells.
Lu Y; Wang L; Li H; Li Y; Ruan Y; Lin D; Yang M; Jin X; Guo Y; Zhang X; Quan C
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867761
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.
Deng J; Lei W; Xiang X; Zhang L; Yu F; Chen J; Feng M; Xiong J
Tumour Biol; 2015 Sep; 36(9):6823-31. PubMed ID: 25846731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
